RESPIRATORY
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
Influenza vaccine is recommended for patients with COPD and booster shot every 5 years
|
|
|
Pneumococcal conjugate vaccines (PCV13 and PPSV23) are recommended for COPD patients over 60 years of age
|
|
|
The pneumococcal conjugate vaccine PPSV23 is recommended for patients younger than 65 years of age with a predicted FEV1 of <40% and particularly with concomitant cardiac or chronic lung disease.
|
|
|
According to GOLD 2021, COPD patients are recommended to be vaccinated against covid 19 (Pfizer vaccine, Moderna vaccine).
|
Detailed explanation-1: -One dose of PPSV23 is recommended for adults: 65 years or older, regardless of previous history of vaccination with pneumococcal vaccines. – Once a dose of PPSV23 is given at age 65 years or older, no additional doses of PPSV23 should be administered. 19 through 64 years with certain medical conditions.
Detailed explanation-2: -PPSV23 protects against 23 types of bacteria that cause pneumococcal disease. PPSV23 is recommended for: All adults 65 years or older, Anyone 2 years or older with certain medical conditions that can lead to an increased risk for pneumococcal disease.
Detailed explanation-3: -All adults 65 and older need two pneumococcal shots: the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Some adults who are 19 to 64 will need two pneumococcal shots-both PCV13 and PPSV23.
Detailed explanation-4: -For those who have not previously received any pneumococcal vaccine†, CDC recommends you: Give 1 dose of PCV15 or PCV20. If PCV15 is used, this should be followed by a dose of PPSV23 at least one year later.